Hepion Pharmaceuticals

About:

Hepion Pharmaceuticals is a clinical stage biopharmaceutical company.

Top Investors: Government of Alberta

Description:

Hepion Pharmaceuticals provides the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV). The company is a biopharmaceutical business that specializes in the creation of medication therapies for the management of chronic liver illnesses. Hepion Pharmaceuticals was established in 2013.

Total Funding Amount:

$135M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Edison, New Jersey, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)hepionpharma.com

Founders:

Robert Foster

Number of Employees:

11-50

Last Funding Date:

2024-07-23

IPO Status:

Public

Industries: